17
Participants
Start Date
February 9, 2006
Primary Completion Date
February 2, 2012
Study Completion Date
February 2, 2012
Lomustine
Starting dose 30 mg/m\^2 by mouth daily on Day 1 and 29.
Temozolomide
75 mg/m\^2 by mouth daily on Days 1 to 42.
Thalidomide
200 mg/m\^2 by mouth daily.
UT MD Anderson Cancer Center, Houston
Collaborators (1)
Celgene Corporation
INDUSTRY
M.D. Anderson Cancer Center
OTHER